Skip to main content

Table 9 Death due to bleeding by predicted risk at baseline

From: The effect of tranexamic acid on the risk of death and hysterectomy in women with post-partum haemorrhage: statistical analysis plan for the WOMAN trial

Risk decilea

Tranexamic acid (TXA)

Placebo

Risk ratio (95 % CI)

 

Death due to bleeding

Received TXA

Death due to bleeding

Received placebo

 

1

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

2

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

3

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

4

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

5

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

6

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

7

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

8

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

9

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

10

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

Overall

NN (X %)

N NNN

NN (X %)

N NNN

X.XX (X.XX–X.XX)

(I 2 = X %, p = 0.XX)

     
  1. Notes
  2. aDeciles of the predicted risk of the outcome at baseline, using a prognostic model including the baseline variables maternal age, estimated blood loss, systolic blood pressure and haemodynamic instability